NLS In a new job

On August 1st, Tomer Feffer started his position as CEO of Bayer Sweden and of the company’s pharmaceutical division in Scandinavia. “It is an honor and a privilege to take over as CEO of Bayer Sweden and become a part of the next phase of a journey that began 71 years ago with the establishment […]

Anders Martin-Löf has been appointed new Chief Financial Officer of Oncopeptides and he will join the company in November. CFO Birgitta Ståhl has decided to step down as the CFO as the company expands the organization in Europe and the US, following a preparation and execution of Oncopeptides’ IPO. She will continue to work in […]

Katarina Ageborg took over the role as Chief Executive Officer after Jan-Olof Jacke on August 1st 2018. Ageborg has been a member of AstraZeneca’s management team since 2011 and she will also maintain her roles as Head of Sustainability and Chief Compliance Officer. “It will be an exciting challenge to take over this role and […]

Mark Goldberger MD MPH infectious disease expert has joined the NDA Advisory Board. Mark brings with him a wealth of experience in and in-depth knowledge of infectious diseases and antimicrobial products as well as extensive FDA expertise, according to the press release. He has insight in these fields, working at the FDA as an expert […]

Karolinska Institutet Holding AB has recruited Hans Möller as the new CEO for the KI Holding Group. “I very much look forward to leading KI Holding into the future. The possibilities and challenges to create the right conditions, to support innovations within Life Science are many. Sweden in general and KI in particular, has a […]

Øyvind Kongstun Arnesen is appointed new chairman at Oslo Cancer Cluster (OCC). Kongstun Arnesen is currently CEO of Ultimovacs and he takes over after Henrik Lund who opted not to stand for re-election after four years in the position. “We look forward to having Øyvind as our chairman. He is very knowledgeable and enthusiastically committed […]